Rigel Pharmaceuticals reported $2.72M in Trade Creditors for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Creditors Change
Agenus AGEN:US USD 39.71M 1.29M
Amgen AMGN:US USD 1.2B 52M
Anika Therapeutics ANIK:US USD 8.35M 188K
Applied Genetic Technologies AGTC:US USD 4.04M 1.13M
Arrowhead Research ARWR:US USD 2.87M 3.03M
Bristol Myers Squibb BMY:US USD 2.6B 287M
Celldex Therapeutics CLDX:US USD 2.27M 1.37M
Daiichi Sankyo 4568:JP JPY 332.22B 1.94B
Eli Lilly And LLY:US USD 1.68B 23.9M
Halozyme Therapeutics HALO:US USD 18.17M 5.93M
Heron Therapeutics HRTX:US USD 6.55M 7.26M
Immunogen IMGN:US USD 20.18M 2.93M
Intrexon XON:US USD 4.2M 1.53M
Karyopharm Therapeutics KPTI:US USD 813K 881K
Macrogenics MGNX:US USD 4.62M 2.01M
Regeneron Pharmaceuticals REGN:US USD 535.6M 1.4M
Rigel Pharmaceuticals RIGL:US USD 2.72M 566K
Sangamo Biosciences SGMO:US USD 17.38M 4.3M
Ultragenyx Pharmaceutical RARE:US USD 23.53M 10.68M
Veracyte VCYT:US USD 11.11M 786K